Evaluating adherence to NCCN guideline-directed genetic screening for patients with pancreatic ductal cell adenocarcinoma in rural northeast Georgia.
Aditya Ghosh(Northeast Georgia Medical Center), Devi Sampat, Oluseyi Abidoye(Mayo Clinic), Sheena Bhushan(Northeast Georgia Medical Center)
Cited by 0
Related Papers
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
|European Journal of Cancer|2024|47
Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer
|Cells|2025|19
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
|The Oncologist|2024|10